HOME >> BIOLOGY >> NEWS
Applied Biosystems and Immune Tolerance Network announce immunology research agreement

Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, and the Immune Tolerance Network (ITN) announced a multi-year agreement to study genes expressed in clinical samples that are believed to be related to immune response modulation in organ transplantation, autoimmune disease, and allergy and asthma. Financial terms of the agreement were not disclosed.

This agreement is a follow-on to a previous program in which the ITN and Applied Biosystems developed a set of functionally validated gene expression assays based on genes predicted to be involved in the modulation of the immune response. In the latest agreement, Applied Biosystems, through its Knowledge Business Genomics Services group, is expected to analyze the set of approximately 1,000 assays in specimens taken from ITN sponsored clinical trials. Under the agreement, ITN will make public the list of genes and clinical trial protocols and Applied Biosystems intends to provide commercial access to the complete assay set by this Spring through its Assays-on-DemandTM Gene Expression Product offering. Approximately two-thirds of the gene expression assays from the ITN set are already available through the enhanced Applied Biosystems e-commerce web site.

ITN intends to use the gene expression data derived from these studies to assess relative expression levels of genes between normal controls and patients, and in single patients at various time points throughout the clinical trials. The data is expected to be used to track parameters such as disease onset, disease progression and patient responses to therapeutics. It is hoped that these studies will result in a better understanding of the mechanisms that relate to the induction, loss and/or maintenance of tolerance and identify new genetic markers for tolerance in humans. Ultimately, this marriage of clinical and genetic sciences in the tolerance arena is designed to improve therapeutic options in organ transplantatio
'"/>


7-Jan-2003


Page: 1 2 3 4

Related biology news :

1. Applied Mathematical Models in Human Physiology
2. Dana-Farber launches Center for Applied Cancer Science
3. Applied Biosystems announces $250,000 grant program for SNP genotyping studies
4. Applied Biosystems announces enhancements to Celera Discovery System and new subscription model
5. Applied Biosystems announces SNPlex ultra high throughput genotyping system
6. Applied Biosystems introduces new chemistries to increase DNA sequencing productivity
7. Applied Biosystems launches Assays-on-Demand SNP genotyping and gene expression products
8. Applied Biosystems introduces new system for protein and metabolite analysis
9. Hutch Researcher Wins Nobel Prize Of Applied Research
10. Biosphere Lessons Can Be Applied To Space, Former Crew Co-Captain Says
11. Immune systems attack dogs kept on genetic leash

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
(Date:4/4/2017)...   EyeLock LLC , a leader of iris-based ... Patent and Trademark Office (USPTO) has issued U.S. Patent ... an iris image with a face image acquired in ... 45 th issued patent. "The ... the multi-modal biometric capabilities that have recently come to ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
Breaking Biology News(10 mins):
(Date:10/9/2017)... 2017  BioTech Holdings announced today identification and ... ProCell stem cell therapy prevents limb loss in ... demonstrated that treatment with ProCell resulted in more ... compared to standard bone marrow stem cell administration.  ... reduction of therapeutic effect.  ...
(Date:10/9/2017)... Arizona (PRWEB) , ... October 09, 2017 , ... ... Kindred, a four-tiered line of medical marijuana products targeting the needs of consumers ... and packaging of Kindred takes place in Phoenix, Arizona. , As operators of ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... launched its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially available ... bioinformatics software to perform Hi-C metagenome deconvolution using their own facilities, supplementing ...
(Date:10/6/2017)... Washington, D.C. (PRWEB) , ... October 06, 2017 ... ... Cure) will host a lunch discussion and webinar on INSIGhT, the first-ever adaptive ... INSIGhT Principal Investigator, Dana-Farber Cancer Institute. The event is free and open to ...
Breaking Biology Technology:
Cached News: